|
Market Closed -
Euronext Paris
11:55:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.7870 EUR | -1.50% |
|
-5.18% | +13.40% |
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Evolution of the Average Target: Valbiotis
Evolution of the Target Price: Valbiotis
Changes in Analyst Recommendations: Valbiotis
835.ggPJRCUgB5Xg6HZoDFT33i5IPfuBKDpvrCrhftp8C-0.1lmvcUdFU_-SggAtRQHClgN_R6zEWkg-nRy2J-M9eqPjdoMmbVZL-IivHQ~0e9d40350249330014daa8459483ca9f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +125.28% | ||||
| +19.12% | ||||||
| +11.09% | ||||||
| +64.75% | ||||||
| +18.05% | ||||||
| +13.05% | ||||||
| +6.66% | ||||||
| +26.26% | ||||||
| -5.63% | ||||||
| +25.87% | ||||||
| Average | +30.45% | |||||
| Weighted average by Cap. | +19.79% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7870EUR
Average target price
1.800EUR
Spread / Average Target
+128.72%
High Price Target
1.800EUR
Spread / Highest target
+128.72%
Low Price Target
1.800EUR
Spread / Lowest Target
+128.72%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ALVAL Stock
- Consensus Valbiotis
Select your edition
All financial news and data tailored to specific country editions
















